Back to Search
JOHN KIRKWOOD, MD
MD
Diagnostic Radiology Physician
NPI: 1467482372Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
037071(MA)030242(CT)
Research & Publications (20)
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
PMID 19092800·Nat Clin Pract Oncol·2009
8-other
Highlights from the perspectives in melanoma XII conference.
PMID 19302131·Pigment Cell Melanoma Res·2009
7-preclinical
Adjuvant therapy with high-dose interferon alpha 2b in patients with high-risk stage IIB/III melanoma.
PMID 18030300·Nat Clin Pract Oncol·2008
8-other
High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.
PMID 11230488·J Clin Oncol·2001
3-trial
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
PMID 11331315·J Clin Oncol·2001
3-trial
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
PMID 19380770·J Immunol·2009
8-other
Liquid crystalline collagen: a self-assembled morphology for the orientation of mammalian cells.
PMID 19437784·Langmuir·2009
7-preclinical
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
PMID 19499546·Int J Cancer·2009
8-other
Phase I/II trial of tremelimumab in patients with metastatic melanoma.
PMID 19139427·J Clin Oncol·2009
3-trial
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.
PMID 19349552·J Clin Oncol·2009
3-trial
Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.
PMID 19228745·Clin Cancer Res·2009
3-trial
Darwinian selection, selective breeding and the welfare of animals.
PMID 19234333·Vet Rec·2009
7-preclinical
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
PMID 19534815·J Transl Med·2009
8-other
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
PMID 19140204·Cancer·2009
3-trial
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.
PMID 19640287·J Transl Med·2009
3-trial
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
PMID 19659612·Pigment Cell Melanoma Res·2009
8-other
Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.
PMID 19364958·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 759 CHESTNUT ST, RADIOLOGY DEPARTMENT
SPRINGFIELD, MA 01107 - Phone
- (413) 827-7426
Quick Facts
- NPI
- 1467482372
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile